HomeRMTI • NASDAQ
add
Rockwell Medical Inc
Previous close
$0.89
Day range
$0.89 - $0.94
Year range
$0.78 - $2.10
Market cap
36.91M USD
Avg Volume
298.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.35M | -25.62% |
Operating expense | 4.28M | 3.04% |
Net income | -554.00K | 26.72% |
Net profit margin | -3.02 | 1.31% |
Earnings per share | — | — |
EBITDA | 148.00K | 516.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.00M | 15.72% |
Total assets | 57.14M | -3.48% |
Total liabilities | 20.16M | -24.26% |
Total equity | 36.98M | — |
Shares outstanding | 39.41M | — |
Price to book | 0.95 | — |
Return on assets | -1.74% | — |
Return on capital | -2.00% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -554.00K | 26.72% |
Cash from operations | 2.29M | 164.86% |
Cash from investing | -4.13M | -1,144.28% |
Cash from financing | -1.06M | -137.93% |
Net change in cash | -2.90M | -187.21% |
Free cash flow | 1.57M | 117.82% |
About
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
244
